interleukin 12 therapy (Ichor)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Nameinterleukin 12 therapy (Ichor)
Drug Alias NameIL-12 (Ichor)IL-12
ClassificationCell and gene therapy > Gene therapy
Mechanisms of ActionInterleukin-12 gene transference
TargetsInterleukin-12
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesIchor Medical Systems Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIchor Medical Systems Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A